
The American Parkinson Disease Association (APDA) held a webinar in December focused on the role and effectiveness of modern medications in Parkinson’s disease (PD) progression, and described two drug therapy approaches. The speaker, movement disorder specialist Dr. Drew Falconer, detailed how contemporary (modern) drug therapy is far superior and preferred in comparison to the classic paradigm for drug therapy. Dr. Falconer noted that today (modern drug therapy) we have 23 medications to treat PD and 12 of them did not exist five years ago. Additionally, Dr. Falconer explained the importance of diagnosing PD correctly as many times PD-like symptoms happen to be parkinsonism but not Parkinson’s disease.
… Full Story>


